Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,063 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Follow-Up Questions
Hologic Inc (HOLX)의 PER은 얼마입니까?
Hologic Inc의 PER은 18.419입니다
Hologic Inc의 CEO는 누구입니까?
Mr. Stephen Macmillan은 2013부터 회사에 합류한 Hologic Inc의 Chairman of the Board입니다.
HOLX 주식의 가격 성능은 어떻습니까?
HOLX의 현재 가격은 $74.07이며, 전 거래일에 decreased 0.04% 하였습니다.
Hologic Inc의 주요 사업 주제나 업종은 무엇입니까?
Hologic Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Hologic Inc의 시가총액은 얼마입니까?
Hologic Inc의 현재 시가총액은 $16.4B입니다
Hologic Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 17명의 분석가가 Hologic Inc에 대한 분석 평가를 실시했으며, 이는 6명의 강력한 매수, 8명의 매수, 13명의 보유, 1명의 매도, 그리고 6명의 강력한 매도를 포함합니다
